How We Can Help
Get More Qualified Leads Using Facebook
The U.S. Food and Drug Administration approved Uloric medication in 2009, and the drug quickly became a popular first choice for treating gout. In 2018, a clinical trial funded by Takeda found an increased risk of heart-related death, as well as death from all causes, in people who took Uloric.
The FDA added a black box warning, the agency’s most serious warning, to Uloric’s label in February 2019, but it left the drug on the market. People who took the medication and suffered cardiovascular events and survivors of people who died have begun filing Uloric lawsuits.
At Law Scout, we build a customizable Facebook campaign to reach Uloric users for your firm who are thoroughly vetted based on YOUR criteria. We can meet your firm’s lead volume needs without sacrificing quality.
A Smarter Way to Find Future Clients
It’s easy to get started, simple to use, and we’re with you each step of the way.